It's about valuating the drug when it is in use. This is just using figures to gain an understanding of the potential Bisantrene can have down the track. Hopefully if a big pharma buys us out then it is up to them to commercialise, mass manufacture and get this out and working to fight as many cancer patients as possible...
At least this is my understanding and I'm more than happy to have an educated response correcting me.
Pillar 1 - FTO (new thread), page-363
-
- There are more pages in this discussion • 2,662 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.53 |
Change
-0.060(3.77%) |
Mkt cap ! $260.7M | |||
| Open | High | Low | Value | Volume |
| $1.59 | $1.59 | $1.53 | $83.43K | 53.65K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 20575 | $1.53 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.57 | 300 | 1 |
View Market Depth
| Last trade - 16.10pm 16/10/2024 (20 minute delay) ? |
| RAC (ASX) Chart |